Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bi...
Q1 2026
Apr 30, 2026
FY 2025
Feb 23, 2026
Q4 2025
Q3 2025
Oct 28, 2025
Q2 2025
Aug 11, 2025
